Fu Hsiu Yin
Directeur/Membre du Conseil chez EIRGENIX INC.
Profil
Fu Hsiu Yin is currently an Independent Director at Sheng Yang Venture Capital Co., Ltd.
and EirGenix, Inc. Previously, Yin served as an Independent Director at PharmaEngine, Inc., Director at TaiGen Biopharmaceuticals Holdings Ltd., and Director at Reber Genetics Co., Ltd.
Yin holds a doctorate degree from Rutgers State University of New Jersey and a graduate degree from National Taiwan University.
Postes actifs de Fu Hsiu Yin
| Sociétés | Poste | Début |
|---|---|---|
| EIRGENIX INC. | Directeur/Membre du Conseil | 13/09/2016 |
| Sheng Yang Venture Capital Co., Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Fu Hsiu Yin
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMAENGINE, INC. | Directeur/Membre du Conseil | - |
| REBER GENETICS CO LTD | Directeur/Membre du Conseil | - |
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Directeur/Membre du Conseil | - |
Formation de Fu Hsiu Yin
| Rutgers State University of New Jersey | Doctorate Degree |
| National Taiwan University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Health Technology |
| PHARMAENGINE, INC. | Health Technology |
| EIRGENIX INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Reber Genetics Co., Ltd.
 Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan. | Health Technology |
| Sheng Yang Venture Capital Co., Ltd. |
